These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26218123)

  • 1. The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymers.
    Sevimli S; Sagnella S; Macmillan A; Whan R; Kavallaris M; Bulmus V; Davis TP
    Biomater Sci; 2015 Feb; 3(2):323-35. PubMed ID: 26218123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
    Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
    Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
    Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-defined cholesterol polymers with pH-controlled membrane switching activity.
    Sevimli S; Inci F; Zareie HM; Bulmus V
    Biomacromolecules; 2012 Oct; 13(10):3064-75. PubMed ID: 22917061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
    Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
    AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
    Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
    Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
    Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalizing biodegradable dextran scaffolds using living radical polymerization: new versatile nanoparticles for the delivery of therapeutic molecules.
    Duong HT; Hughes F; Sagnella S; Kavallaris M; Macmillan A; Whan R; Hook J; Davis TP; Boyer C
    Mol Pharm; 2012 Nov; 9(11):3046-61. PubMed ID: 23078353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
    Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.
    Liu J; Deng H; Liu Q; Chu L; Zhang Y; Yang C; Zhao X; Huang P; Deng L; Dong A; Liu J
    Nanoscale; 2015 Mar; 7(10):4451-60. PubMed ID: 25679795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H; Liu M; Yu A; Ji J; Zhai G
    Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyanionic holothurian glycosaminoglycans-doxorubicin nanocomplex as a delivery system for anticancer drugs.
    Mou J; Wu Y; Bi M; Qi X; Yang J
    Colloids Surf B Biointerfaces; 2018 Jul; 167():364-369. PubMed ID: 29698785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.